Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03723863 · ClinicalTrials.gov registry record · NA

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

A NA study, sponsored by University of Washington.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT03723863: Clinical Trial NA study, sponsored by University of Washington.

NCT03723863 is a NA study that was terminated before completion, run by University of Washington. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03723863, a NA study, was terminated before completion, sponsored by University of Washington.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This trial studies how well occupational therapy (occupational therapist-led work intervention) works in facilitating work maintenance or re-entry to the workforce for stages I to III breast cancer patients who will be undergoing curative intent chemotherapy. Occupational therapy may help cancer patients maintain employment or successfully return to work soon after treatment.

Primary Outcome

Will be measured by the Work Abilities Index (WAI).

Interventions

  • BEHAVIORAL Occupational Therapy

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-10-25
Est. Completion 2020-09-22
Phase NA
University of Washington

1,048 total trials

Why NCT03723863 stopped before completion

NCT03723863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Occupational Therapy is the first listed.

NCT03723863 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03723863 about?

NCT03723863 is a clinical study titled "Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy". This trial studies how well occupational therapy (occupational therapist-led work intervention) works in facilitating work maintenance or re-entry to the workforce for stages I to III breast cancer patients who will be undergoing curative intent chemotherapy. Occupational therapy may help cancer pat...

What is the current status of trial NCT03723863?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2018-10-25. Estimated completion is 2020-09-22.

What interventions are being tested in trial NCT03723863?

The interventions under investigation include: Occupational Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03723863?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03723863's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03723863, the US trial registry maintained by the National Library of Medicine. NCT03723863 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.